Graham Brock
About Graham Brock
Graham Brock is the Director of CDx and Biomarker Development at BeiGene, with over 20 years of experience in biomarker development and research.
Current Role at BeiGene
Graham Brock is currently serving as the Director of CDx and Biomarker Development at BeiGene. He joined the company in May 2017 and has since been instrumental in advancing biomarker research and development. With over 20 years of experience in the field, he contributes his extensive expertise in leading research teams and managing laboratory operations.
Previous Experience at Exosome Diagnostics
Between 2014 and 2016, Graham Brock held the position of Director of Research at Exosome Diagnostics in Cambridge, Massachusetts. During his tenure, he was responsible for pioneering research initiatives and guiding the organization's strategic direction in biomarker discovery.
Biomarker Consultant and Lead at Locus Genetics
From 2013 to 2014, Graham Brock worked at Locus Genetics as a Biomarker Consultant and Lead. His role involved providing expert guidance on biomarker strategies and contributing to the company's research and development activities.
Principal Scientist at Biogen
Graham Brock served as a Principal Scientist and Lab Lead at Biogen from 2011 to 2013. In this role, he was responsible for overseeing laboratory operations and spearheading research projects aimed at discovering and developing new biomarkers.
Academic Background
Graham Brock holds a Doctor of Philosophy from the University of Edinburgh's School of Philosophy, Psychology, and Language Sciences, achieved from 1994 to 1997. Prior to that, he earned a Bachelor of Science from Heriot-Watt University Malaysia, which he attended from 1989 to 1993. His strong academic foundation has underpinned his successful career in biomarker development and research.